amodiaquine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kambey, PA | 1 |
| Chengcheng, M | 1 |
| Xiaoxiao, G | 1 |
| Abdulrahman, AA | 1 |
| Kanwore, K | 1 |
| Nadeem, I | 1 |
| Jiao, W | 1 |
| Gao, D | 1 |
1 other study available for amodiaquine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
Topics: Amodiaquine; Animals; Brain; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agen | 2021 |